SCHEMBL5481379

SCHEMBL5481379

COc1ccc(-c2ccnc(N)c2C#N)c(OC)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.46
HPGD P15428 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPK1 P28482 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
PRKACA P17612 1/20 0.43
PRKACG P22612 1/20 0.43
PRKACB P22694 1/20 0.43
ALDH1A1 P00352 5/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 1/20 0.41
GLA P06280 1/20 0.41
GFER P55789 1/20 0.41
KMT2A Q03164 1/20 0.41
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
PDE10A Q9Y233 1/20 0.39
HSD17B10 Q99714 2/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5483595 0.88 ALDH1A1 (0.45) KDM4EHPGDL3MBTL1MAPK1PRKACA
SCHEMBL5480724 0.80 ALDH1A1 (0.56) KDM4EHPGDL3MBTL1PRKACAPRKACG
SCHEMBL5481371 0.80 MAPK1 (0.45) KDM4EHPGDL3MBTL1MAPK1SMN1; SMN2
SCHEMBL564697 0.77 ALDH1A1 (0.53) KDM4EHPGDL3MBTL1MAPK1PRKACA
SCHEMBL27782978 0.71 RAD52 (0.42) KDM4EHPGDL3MBTL1MAPK1SMN1; SMN2
SCHEMBL642228 0.71 HDAC4 (0.58) KDM4EHPGDMAPK1SMN1; SMN2ALDH1A1
SCHEMBL22235384 0.69 NOS3 (0.41) SMN1; SMN2ALDH1A1GAANPC1
SCHEMBL5481376 0.69 PRKCQ (0.45) KDM4EHPGDL3MBTL1MAPK1SMN1; SMN2
SCHEMBL5482017 0.69 LMNA (0.50) KDM4EHPGDL3MBTL1ALDH1A1MAPT
SCHEMBL10757785 0.69 ALDH1A1 (0.46) KDM4EHPGDL3MBTL1MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors WYETH 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors CNKSR1, MAP3K1, MAP3K6 KDM4E 959/4885HPGD 2446/4885L3MBTL1 2767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.